Takeda Pharmaceutical as of June 30, 2025
Portfolio Holdings for Takeda Pharmaceutical
Takeda Pharmaceutical holds 11 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Hillevax | 68.4 | $13M | 6.7M | 1.99 | |
| Ovid Therapeutics (OVID) | 12.7 | $2.5M | 7.5M | 0.33 | |
| Xilio Therapeutics (XLO) | 5.1 | $1.0M | 1.5M | 0.68 | |
| American Well Corp-class A (AMWL) | 3.5 | $691k | 78k | 8.89 | |
| Equillium (EQ) | 2.9 | $575k | 1.8M | 0.32 | |
| Shattuck Labs (STTK) | 2.1 | $408k | 516k | 0.79 | |
| Lyell Immunopharma | 1.9 | $364k | 41k | 8.84 | |
| Turnstone Biologics Corp (TSBX) | 1.6 | $322k | 896k | 0.36 | |
| Third Harmonic Bio (THRD) | 1.0 | $200k | 37k | 5.43 | |
| Rani Therapeutics Hldgs (RANI) | 0.5 | $104k | 203k | 0.51 | |
| D Fluidigm Corp Del (LAB) | 0.1 | $20k | 17k | 1.20 |
